Cargando…
Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194518/ http://dx.doi.org/10.1186/1546-0096-9-S1-P164 |
| _version_ | 1782213990130122752 |
|---|---|
| author | De Benedetti, F Brunner, H Ruperto, N Schneider, R Woo, P Burgos-Vargas, R Dolezalova, P Joos, R Wulffraat, N Zuber, Z Zulian, F Allen, R Brown, D Chaitow, J Pardeo, M Espada, G Flato, B Gerloni, V Horneff, G Wright, S Kenwright, A Lovell, D Martini, A |
| author_facet | De Benedetti, F Brunner, H Ruperto, N Schneider, R Woo, P Burgos-Vargas, R Dolezalova, P Joos, R Wulffraat, N Zuber, Z Zulian, F Allen, R Brown, D Chaitow, J Pardeo, M Espada, G Flato, B Gerloni, V Horneff, G Wright, S Kenwright, A Lovell, D Martini, A |
| author_sort | De Benedetti, F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3194518 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31945182011-10-18 Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data De Benedetti, F Brunner, H Ruperto, N Schneider, R Woo, P Burgos-Vargas, R Dolezalova, P Joos, R Wulffraat, N Zuber, Z Zulian, F Allen, R Brown, D Chaitow, J Pardeo, M Espada, G Flato, B Gerloni, V Horneff, G Wright, S Kenwright, A Lovell, D Martini, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2011-09-14 /pmc/articles/PMC3194518/ http://dx.doi.org/10.1186/1546-0096-9-S1-P164 Text en Copyright ©2011 De Benedetti et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation De Benedetti, F Brunner, H Ruperto, N Schneider, R Woo, P Burgos-Vargas, R Dolezalova, P Joos, R Wulffraat, N Zuber, Z Zulian, F Allen, R Brown, D Chaitow, J Pardeo, M Espada, G Flato, B Gerloni, V Horneff, G Wright, S Kenwright, A Lovell, D Martini, A Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data |
| title | Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data |
| title_full | Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data |
| title_fullStr | Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data |
| title_full_unstemmed | Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data |
| title_short | Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data |
| title_sort | efficacy and safety of tocilizumab (tcz) in patients with systemic juvenile idiopathic arthritis (sjia): tender 52-week data |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194518/ http://dx.doi.org/10.1186/1546-0096-9-S1-P164 |
| work_keys_str_mv | AT debenedettif efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT brunnerh efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT ruperton efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT schneiderr efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT woop efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT burgosvargasr efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT dolezalovap efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT joosr efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT wulffraatn efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT zuberz efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT zulianf efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT allenr efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT brownd efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT chaitowj efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT pardeom efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT espadag efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT flatob efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT gerloniv efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT horneffg efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT wrights efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT kenwrighta efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT lovelld efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata AT martinia efficacyandsafetyoftocilizumabtczinpatientswithsystemicjuvenileidiopathicarthritissjiatender52weekdata |